Shanghai Shale Technology

Shale Technology is a Shanghai-based biotechnology company specializing in AI-driven drug discovery. The company leverages a proprietary platform that combines physics-based simulations with deep learning to accelerate the identification and optimization of novel small molecule candidates. Their approach focuses on high-precision molecular dynamics and free energy calculations to tackle challenging biological targets that are often considered undruggable. Shale Technology aims to bridge the gap between computational predictions and experimental validation to improve the success rate of drug development. The firm has secured significant venture capital funding from prominent investors like Sequoia China and Source Code Capital to advance its internal pipeline and collaborative projects.